First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Urinary Bladder Diseases

Back to Details
This is a "connection" page, showing publications Karl-Erik Andersson has written about Urinary Bladder Diseases.
Karl-Erik Andersson
Connection Strength
5.313
Urinary Bladder Diseases
  1. Andersson KE. Oxidative stress and its possible relation to lower urinary tract functional pathology. BJU Int. 2018 04; 121(4):527-533.
    View in: PubMed
    Score: 0.524
  2. Andersson KE. Words of wisdom. Re: Tissue engineering of the bladder: reality or myth? A systematic review. Eur Urol. 2014 Sep; 66(3):593.
    View in: PubMed
    Score: 0.420
  3. Andersson KE. Bladder underactivity. Eur Urol. 2014 Feb; 65(2):399-401.
    View in: PubMed
    Score: 0.397
  4. Nomiya M, Yamaguchi O, Akaihata H, Hata J, Sawada N, Kojima Y, Andersson KE. Progressive vascular damage may lead to bladder underactivity in rats. J Urol. 2014 May; 191(5):1462-9.
    View in: PubMed
    Score: 0.396
  5. Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013 Apr; 93(2):653-80.
    View in: PubMed
    Score: 0.381
  6. Soler R, Füllhase C, Hanson A, Campeau L, Santos C, Andersson KE. Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease. J Urol. 2012 Apr; 187(4):1491-7.
    View in: PubMed
    Score: 0.352
  7. Andersson KE. Neurourology and Urodynamics. Editorial. Neurourol Urodyn. 2011 Sep; 30(7):1207.
    View in: PubMed
    Score: 0.341
  8. Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, Rosenbaum JS, Hedlund P, Andersson KE. Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction. J Urol. 2011 Feb; 185(2):731-6.
    View in: PubMed
    Score: 0.325
  9. Andersson KE. Detrusor underactivity/underactive bladder: new research initiatives needed. J Urol. 2010 Nov; 184(5):1829-30.
    View in: PubMed
    Score: 0.319
  10. Soler R, Füllhase C, Lu B, Bishop CE, Andersson KE. Bladder dysfunction in a new mutant mouse model with increased superoxide--lack of nitric oxide? J Urol. 2010 Feb; 183(2):780-5.
    View in: PubMed
    Score: 0.306
  11. Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009 Nov; 56(5):810-9.
    View in: PubMed
    Score: 0.295
  12. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004 Jul; 84(3):935-86.
    View in: PubMed
    Score: 0.208
  13. Andersson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol. 2004 Jan; 3(1):46-53.
    View in: PubMed
    Score: 0.200
  14. Andersson KE. Treatment of the overactive bladder: possible central nervous system drug targets. Urology. 2002 May; 59(5 Suppl 1):18-24.
    View in: PubMed
    Score: 0.179
  15. Ito H, Kamei J, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Fujimura T, Kojima T, Homma Y, Kubota Y, Ito M, Andersson KE, Igawa Y. Preventive Effects of Long-Term Caloric Restriction on Aging Related In Vivo Bladder Dysfunction and Molecular Biological Changes in the Bladder and Dorsal Root Ganglia in Rats. J Urol. 2016 11; 196(5):1575-1583.
    View in: PubMed
    Score: 0.118
  16. Ito H, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Homma Y, Kubota Y, Ito M, Andersson KE, Igawa Y. Long-term caloric restriction in rats may prevent age related impairment of in vitro bladder function. J Urol. 2015 Jun; 193(6):2123-30.
    View in: PubMed
    Score: 0.106
  17. Malykhina AP, Wyndaele JJ, Andersson KE, De Wachter S, Dmochowski RR. Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. Neurourol Urodyn. 2012 Mar; 31(3):352-8.
    View in: PubMed
    Score: 0.088
  18. Gomez-Pinilla PJ, Gomez MF, Swärd K, Hedlund P, Hellstrand P, Camello PJ, Andersson KE, Pozo MJ. Melatonin restores impaired contractility in aged guinea pig urinary bladder. J Pineal Res. 2008 May; 44(4):416-25.
    View in: PubMed
    Score: 0.066
  19. Christ G, Andersson KE, Atala A. The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering. Curr Urol Rep. 2007 Mar; 8(2):95-9.
    View in: PubMed
    Score: 0.062
  20. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 2005 Apr; 95(6):733-8.
    View in: PubMed
    Score: 0.055
  21. Andersson KE. Storage and voiding symptoms: pathophysiologic aspects. Urology. 2003 Nov; 62(5 Suppl 2):3-10.
    View in: PubMed
    Score: 0.050
  22. Staskin DR, Wein AJ, Andersson KE, Bauer SB, Blaivas JG, Burgio KL, Cardozo L, Chapple CR, Dmochowski RR, Gupta S, Mostwin JL, Ouslander JG, Weiss JP, King L. Overview consensus statement. Urology. 2002 Nov; 60(5 Suppl 1):1-6.
    View in: PubMed
    Score: 0.046
  23. Andersson KE, Hedlund P. Pharmacologic perspective on the physiology of the lower urinary tract. Urology. 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1.
    View in: PubMed
    Score: 0.046
  24. Vahabi B, Wagg AS, Rosier PFWM, Rademakers KLJ, Denys MA, Pontari M, Lovick T, Valentini FA, Nelson PP, Andersson KE, Fry CH. Can we define and characterize the aging lower urinary tract?-ICI-RS 2015. Neurourol Urodyn. 2017 04; 36(4):854-858.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.